ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1176 • ACR Convergence 2020

    Identifying Targets to Improve the Assessment of Psychosocial Risk Factors in Adolescent Patients: Perspectives from Pediatric Rheumatology Fellows in the United States and Canada

    Jacob Spitznagle1, Nayimisha Balmuri1, Alexa Adams1, Karen Onel2, Sarah Taber1 and Nancy Pan1, 1Hospital for Special Surgery, New York, NY, 2Pediatric Rheumatology, Hospital for Special Surgery, New York, NY

    Background/Purpose: Adolescent patients cared for in the pediatric rheumatology clinic balance challenges related to psychosocial stressors and physical growth with the complexities of living with…
  • Abstract Number: 1182 • ACR Convergence 2020

    Increased Prevalence of Carotid Atherosclerosis in Postmenopausal Women with Rheumatoid Arthritis: A Case Control Study

    Dionicio Ángel Galarza-Delgado1, José Ramón Azpiri López2, Iris Jazmín Colunga Pedraza3, Mayra Alejandra Reyes Soto3, Alejandra Pérez Villar3, Itzel Corina Zárate Salinas2, Paola Fernanda Frausto Lerma3 and Salvador Lugo Pérez2, 1Rheumatology Service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Cardiology Service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Mexico, 3Rheumatology service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Mexico

    Background/Purpose: Cardiovascular disease (CVD) is the primary cause of mortality in women in developed countries. CVD risk rises with age, yet for women there is…
  • Abstract Number: 1181 • ACR Convergence 2020

    Gains in Cardiovascular Risk Knowledge Through Web Based Educational Intervention for Rheumatoid Arthritis Patients

    Meenakshi Jolly1, Courtney O'Brien1, Aman Kugasia2, Anna Gorfin3, Lauren Klebek3, Joshlean Fair3 and Joel Block1, 1Rush University, Chicago, IL, 2Arthritis Clinic of Cypress and Katy, PA, Katy, TX, 3Rush University, Chicago

    Background/Purpose: Cardiovascular disease (CVD) is a leading cause of mortality in rheumatoid arthritis (RA). Ischemic heart disease in RA is often silent and precedes myocardial…
  • Abstract Number: 1187 • ACR Convergence 2020

    Red Cell Distribution Width Is Associated with ASCVD Risk Score and CVD in RA After Initiation of Methotrexate

    Ibtissam Gad1, Sofi Damjanovska2, Lenche Kostadinova3, Alyssa Lange4, Christopher Burant4, Brigid Wilson5, Taissa Bej5, Nora Singer6, Maya Mattar7, David Zidar8 and Donald Anthony9, 1Case Western Reserve/ Cleveland VA Medical Center, Cleveland Heights, OH, 2Case Western Reserve University/Cleveland VA Medical Center, Cleveland Heights, OH, 3(1) Department of Medicine, VA Medical Center and VA GRECC, Case Western Reserve University, Cleveland OH, Highland Heights, OH, 4Case Western Reserve University, Cleveland, 5Department of Medicine, VA Medical Center and VA GRECC, Case Western Reserve University, Cleveland OH, Cleveland, 6The MetroHealth System, Case Western Reserve University School of Medicine, Cleveland, OH, 7Department of Medicine, VA Medical Center and VA GRECC, Case Western Reserve University, Cleveland OH, Cleveland, OH, 8Case Western Reserve University/Cleveland VA Medical Center, Cleveland, 9Case Western Reserve University/Cleveland VA Medical Center/MetroHealth Medical Center, Cleveland, OH

    Background/Purpose: Rheumatoid arthritis (RA) has been shown to be associated with increased risk of cardiovascular disease (CVD)  and mortality. Red cell distribution width (RDW) represents…
  • Abstract Number: 1189 • ACR Convergence 2020

    Serum High-sensitive Cardiac Troponin at Baseline Predict Cardiovascular Events in Rheumatoid Arthritis and Osteoarthritis

    M. Elaine Husni1, Daniel H Solomon2, Mingyuan Shao3, Katherine Wolski3, Steven Nissen3, Stanley Hazen4 and WH Wilson Tang4, 1Cleveland Clinic, Cleveland, OH, 2Brigham and Women's Hospital, Boston, MA, 3Cleveland Clinic Foundation, Cleveland, OH, 4Cleveland Clinic Foundation, Cleveland

    Background/Purpose: In rheumatoid arthritis (RA), excess mortality and inflammation has been attributed to cardiovascular (CV) diseases. High-sensitivity cardiac troponins (hscTnT) allow measurement of cardiac troponin…
  • Abstract Number: 1184 • ACR Convergence 2020

    In a Prospective RA Cohort, Higher Baseline Disease Activity Is an Independent Predictor of Decline in Left Ventricular Diastolic Function

    Elizabeth Park1, Kazato Ito2, Christopher Depender1, Jon Giles1 and Joan Bathon1, 1Division of Rheumatology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, 2Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY

    Background/Purpose: Rheumatoid Arthritis (RA) patients are at nearly 50% increased risk of heart failure (HF) compared to non-RA patients, despite adjusting for the presence of…
  • Abstract Number: 1179 • ACR Convergence 2020

    Cardiovascular Risk Assessment with Carotid Ultrasonography in Addition to the Traditional Cardiovascular Risk Factor in Rheumatoid Arthritis: A Case Control Study

    Roxana Gonzalez Mazario1, Jorge Juan Fragio Gil1, Marta De la Rubia Navarro1, Cristobal Pavez Perales1, Samuel Leal Rodriguez2, Jose Ivorra Cortes1, Luis Gonzalez Puig3, Elena Grau Garcia2, Elvira Vicens Bernabeu1, F Ortiz-Sanjuan1, Rosa Negueroles Albuixech1, Cristina Alcañiz Escandell2, Jose Eloy Oller Rodriguez1, Inmaculada Chalmeta Verdejo1, Isabel Martinez Cordellat1, Carmen Najera Herranz1, Ines Canovas Olmos1, Antonio Cañada Martínez4 and Jose Andres Roman Ivorra1, 1Rheumatology Department. HUP La Fe, Valencia, Spain, 2Rheumatology Department. HUP La Fe, Valencia, Comunidad Valenciana, Spain, 3Rheumatology Department. HUP La Fe, Torrente ( Valencia), Spain, 4HUP La Fe, Valencia, Spain

    Background/Purpose: To assess the Cardiovascular Risk (CV) in Rheumatoid Arthritis (RA) patients using carotid ultasonography additionally to the traditional CV risk factors.Methods: A single center…
  • Abstract Number: 1192 • ACR Convergence 2020

    Subclinical Coronary Calcification Associated with Long-term Cardiovascular Outcomes in Rheumatoid Arthritis

    George Karpouzas1, Sarah Ormseth1, Elizabeth Hernandez1 and Matthew Budoff1, 1Harbor-UCLA Medical Center and the Lundquist Institute, Torrance, CA

    Background/Purpose: Large, multicenter studies established the strong prognostic value of coronary artery calcium (CAC) scoring in asymptomatic individuals. Increasing CAC score is an independent predictor…
  • Abstract Number: 1195 • ACR Convergence 2020

    MUC5B rs35705950 and Rheumatoid Arthritis Associated Interstitial Lung Disease Progression

    Pierre-Antoine Juge1, Joshua Solomon2, Romain Garofoli3, Joyce S. Lee4, Fabienne Louis-Sidney5, Esther Ebstein1, Jorge Rojas-Serrano6, Montserrat I. Gonzalez-Perez6, Mayra Mejia6, Ivette Buendia-Roldan6, Ramces Falfan-Valencia7, Enrique Ambrocio-Ortiz7, Effrosyni Manali8, Spyros A. Papiris8, Theofanis Karageorgas9, Dimitrios Boumpas9, Katarina Antoniou10, Coline H.M. van Moorsel11, Joanne van Der Vis11, Yaël A. de Man11, Jan C. Grutters11, Caroline Kannengiesser12, Raphaël Borie13, Lidwine Wemeau-Stervinou14, Rene-Marc Flipo15, Hilario Nunes16, Yurdagul Uzunhan17, Dominique Valeyre18, Nathalie Saidenberg Kermanac'h19, Marie-Christophe Boissier20, Christophe Richez21, Thierry Schaeverbeke22, Tracy J. Doyle23, Paul Wolters24, Marie-Pierre Debray25, Catherine Boileau12, Raphaël Porcher26, Bruno Crestani13, David A. Schwartz4 and Philippe Dieude27, 1Université de Paris, Service de Rhumatologie Hôpital Bichat-Claude Bernard, AP-HP, Paris, France, 2National Jewish Health, Denver, CO, 3Hôpital Cochin, Service de Rééducation, Paris, Paris, France, 4Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA, Aurora, CO, 5Service de Rhumatologie, CHU de Fort de France, Martinique, France, Fort de France, France, 6Interstitial Lung Disease & Rheumatology Unit, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, México City, México, Mexico, Mexico, 7HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas. Mexico City, Mexico, Mexico, Mexico, 82nd Pulmonary Medicine Department, University Hospital of Athens "Attikon", National and Kapodistrian University of Athens, Greece, Athens, Greece, 9Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, University Hospital of Athens "Attikon", National and Kapodistrian University of Athens, Greece, Athens, Greece, 10PS Department of Respiratory Medicine & Laboratory of Molecular & Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete, Greece, Heraklion, Greece, 11St Antonius ILD center of excellence, St Antonius ziekenhuis, Nieuwegein, The Netherlands, Nieuwegein, Netherlands, 12Université de Paris, Hôpital Bichat, Service de Génétique, AP-HP, Paris, Paris, France, 13Université de Paris, Service de Pneumologie Hôpital Bichat-Claude Bernard, AP-HP, Paris, France, 14CHRU de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de compétence des maladies pulmonaires rares, FHU IMMINENT, Lille, France, Lille, France, 15Lille University Hospital, Lille, France, 16Department of Pulmonology, Hôpital Avicenne, APHP, Bobigny, France, Bobigny, France, 17Hôpital Avicennes, Service de Pneumologie, AP-HP, Bobigny, Bobigny, France, 18Hôpital Avicenne, Service de pneumologie, AP-HP, Bobigny, Bobigny, France, 19Hôpital Avicennes, Service de Rhumatologie, AP-HP, Bobigny, Bobigny, France, 20Hôpital Avicenne, Service de Rhumatologie, AP-HP, Bobigny, Bobigny, France, 21Rheumatology Hospital, Pelligrin Hospital, Bordeaux University Hospital, Bordeaux, France, 22CHU de Bordeaux, Service de Rhumatologie, Bordeaux, France, 23Brigham and Women's Hospital, West Roxbury, MA, 24University of California, San Francisco, San Francisco, CA, 25Université de Paris, Service de Radiologie Hôpital Bichat-Claude Bernard, AP-HP, Paris, France, 26Centre d’Epidémiologie Clinique, AP-HP, Hôpital Hôtel-Dieu, F-75004 Paris, France, Paris, France, 27Université de Paris, Service de Rhumatologie Hôpital Bichat-Claude Bernard, AP-HP, Paris, Ile-de-France, France

    Background/Purpose: Rheumatoid arthritis (RA) associated interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF) sharephenotypic and genotypic similarities. Recently, in a large international genetic association…
  • Abstract Number: 1196 • ACR Convergence 2020

    Associations of Biological Sex with Interstitial Lung Disease in Patients with Rheumatoid Arthritis Are Independent of Other Known Risk Factors

    Austin Wheeler1, Gail Kerr2, Ilona Jileaeva3, Asha Krishna4, Bryant England1, Harlan Sayles1, Geoffrey Thiele1, Jill Poole1, Alison Petro1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2Washington DC VA Medical Center, Washington, DC, 3Howard University Hospital, Washington, DC, 4Washington, D.C. VAMC, Washington, DC

    Background/Purpose: Extra-articular manifestations of rheumatoid arthritis (RA), such as nodules and interstitial lung disease (ILD), portend poor outcomes and are more common in men than…
  • Abstract Number: 1191 • ACR Convergence 2020

    Specificity for Inflammatory Pathways Associated with Coronary Microvascular Dysfunction in Rheumatoid Arthritis

    Brittany Weber1, Zeling He1, Sicong Huang1, Daniel H. Solomon2, Elena Massarotti1, Charlotte Golnik1, Thany Seyok1, Seth Brownmiller1, Laurel Martell1, Leann Barrett1, Courtney Bibbo1, Marcy Bolster3, Marcelo DiCarli1 and Katherine Liao1, 1Brigham and Women's Hospital, Boston, MA, 2Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 3Massachusetts General Hospital, Concord, MA

    Background/Purpose: Coronary microvascular disease (CMD) is associated with increased mortality in RA independent of traditional cardiovascular (CV) risk factors. Inflammation likely plays an important role…
  • Abstract Number: 1202 • ACR Convergence 2020

    Cannabis Use Assessment and Its Impact on Pain in Rheumatic Diseases: A Systematic Review and Meta-analysis

    Manon Guillouard1, Nicolas Authier1, Bruno Pereira1, Martin Soubrier1 and Sylvain Mathieu1, 1CHU Gabriel Montpied, Clermont-Ferrand, France

    Background/Purpose: Despite classic analgesic or effective treatments in rheumatic diseases, such as synthetic Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis (RA), patients remain in pain…
  • Abstract Number: 1199 • ACR Convergence 2020

    Prevalence of Subclinical Interstitial Lung Disease After a Mean Rheumatoid Arthritis Duration of 13 Years: Results from the French ESPOIR Cohort

    Pierre-Antoine Juge1, Marie-Pierre Debray2, Esther Ebstein1, Raphaël Borie3, Arnaud Constantin4, Bernard Combe5, Bruno Fautrel6, Rene-Marc Flipo7, Xavier Mariette8, Olivier Vittecoq9, Alain Saraux10, Guillermo Carvajal Alegria11, Jean Sibilia12, Francis Berenbaum13, Bruno Crestani3 and Philippe Dieude14, 1Université de Paris, Service de Rhumatologie Hôpital Bichat-Claude Bernard, AP-HP, Paris, France, 2Université de Paris, Service de Radiologie Hôpital Bichat-Claude Bernard, AP-HP, Paris, France, 3Université de Paris, Service de Pneumologie Hôpital Bichat-Claude Bernard, AP-HP, Paris, France, 4Hospital Pierre Paul Riquet, Toulouse, France, 5University of Montpellier, Montpellier, France, 6Sorbonne University, INSERM, IPLES; Pitié-Salpêtrière Hospital, Paris, Ile-de-France, France, 7Lille University Hospital, Lille, France, 8Paris-Sud University, Rueil-Malmaison, France, 9University Hospital of Rouen, Rouen, France, 10Department of Rheumatology, UBO, CHU, INSERM 1227 (LBAI), Brest, France, 11CHU de Brest, Service de Rhumatologie, Brest, France, 12Department of rheumatology, University Hospitals of Strasbourg and French National Reference Center for Rare Auto-immune diseases, Strasbourg, France, 13AP-HP, Hôpital Saint-Antoine, Service de Rhumatologie, Centre de Recherche Saint-Antoine, INSERM UMR_S 938,Sorbonne Université, Paris, 75012, France, Paris, France, 14Université de Paris, Service de Rhumatologie Hôpital Bichat-Claude Bernard, AP-HP, Paris, Ile-de-France, France

    Background/Purpose: Interstitial lung disease (ILD) is a frequent extra-articular manifestation of rheumatoid arthritis (RA). It is associated with a high morbi-mortality. However, the exact prevalence…
  • Abstract Number: 1194 • ACR Convergence 2020

    MUC5B Promoter Variant rs35705950 and Risk Stratification for Rheumatoid Arthritis – Interstitial Lung Disease

    Pierre-Antoine Juge1, Fabienne Louis-Sidney2, Benjamin Granger3, Joanna Kedra4, Marie-Pierre Debray5, Esther Ebstein1, Raphaël Borie6, Arnaud Constantin7, Bernard Combe8, Rene-Marc Flipo9, Xavier Mariette10, Olivier Vittecoq11, Alain Saraux12, Guillermo Carvajal Alegria13, Jean Sibilia14, Francis Berenbaum15, Caroline Kannengiesser16, Bruno Crestani6, Catherine Boileau16, Bruno Fautrel17 and Philippe Dieude18, 1Université de Paris, Service de Rhumatologie Hôpital Bichat-Claude Bernard, AP-HP, Paris, France, 2Service de Rhumatologie, CHU de Fort de France, Martinique, France, Fort de France, France, 3Département de Biostatistiques, Santé Publique et Information Médicale, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Paris, France., Paris, France, 4Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, UMR S1136, Paris, France, Paris, France, 5Université de Paris, Service de Radiologie Hôpital Bichat-Claude Bernard, AP-HP, Paris, France, 6Université de Paris, Service de Pneumologie Hôpital Bichat-Claude Bernard, AP-HP, Paris, France, 7Hospital Pierre Paul Riquet, Toulouse, France, 8University of Montpellier, Montpellier, France, 9Lille University Hospital, Lille, France, 10Paris-Sud University, Rueil-Malmaison, France, 11University Hospital of Rouen, Rouen, France, 12Department of Rheumatology, UBO, CHU, INSERM 1227 (LBAI), Brest, France, 13CHU de Brest, Service de Rhumatologie, Brest, France, 14CHU Strasbourg, Service de Rhumatologie, Strasbourg, France, 15AP-HP, Hôpital Saint-Antoine, Service de Rhumatologie, Centre de Recherche Saint-Antoine, INSERM UMR_S 938,Sorbonne Université, Paris, 75012, France, Paris, France, 16Université de Paris, Hôpital Bichat, Service de Génétique, AP-HP, Paris, Paris, France, 17Sorbonne University, INSERM, IPLES; Pitié-Salpêtrière Hospital, Paris, Ile-de-France, France, 18Université de Paris, Service de Rhumatologie Hôpital Bichat-Claude Bernard, AP-HP, Paris, Ile-de-France, France

    Background/Purpose: Interstitial lung disease (ILD) is an extra-articular manifestation of rheumatoid arthritis (RA) detected in 20 to 60% of patients with RA on high-resolution computed-tomography…
  • Abstract Number: 1086 • ACR Convergence 2020

    The Diagnostic Value and Clinical Significance of Myositis-Specific Antibodies in Patients Suspected to Have Autoimmune Myopathies and/or Autoimmune Rheumatic Diseases

    Sarah El Chami1, Christopher Williams1, Ghaith Noaiseh1, Amrita Bath1 and Duaa Jabari1, 1The University of Kansas Health System, Kansas city, KS

    Background/Purpose: Myositis-specific antibodies (MSA) are thought to be highly specific in patients with idiopathic inflammatory myopathies.[1] However, in clinical practice these antibodies are frequently found…
  • « Previous Page
  • 1
  • …
  • 704
  • 705
  • 706
  • 707
  • 708
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology